Introduction {#S1}
============

Since December 2019, the novel coronavirus severe acute respiratory syndrome CoV-2 (SARS-CoV-2), which was first reported in Wuhan City in China, is spreading rapidly throughout the world and places an immense threat and severe challenges on global public health ([@B48]). On March 11, 2020, the World Health Organization (WHO) officially classified the spread of SARS-CoV-2 as a pandemic ([@B43]). The number of confirmed cases worldwide has reached 4,248,389, including 292,046 deaths, until May 14th 2020 ([@B42]). The clinical picture of reported SARS-CoV-2 infections seems to be heterogenic, ranging from asymptomatic infections and mild respiratory diseases, to severe viral pneumonia with respiratory failure and even death in a small proportion of patients ([@B47]). First studies, investigating possible risk factors for a severe course of disease or worse prognosis and implications of comorbid conditions, emerge. The results of a meta-analysis by [@B44] including 46,248 infected patients in China, suggest that the most prevalent comorbid conditions were hypertension (17%) followed by diabetes (8%), cardiovascular disease (5%), and respiratory illness (2%). Overall, patients with a severe course of disease were older and had a higher number of comorbidities than those with a non-severe course of disease ([@B40]) suggesting older age and comorbid conditions as risk factors for infection and worse prognosis ([@B44]).

Cancer is one of the most common diseases in the world and an increasingly global health issue ([@B13]). In regard to SARS-CoV-2, only preliminary research of the effect of a comorbid cancer diagnose exists. The prospective investigation by [@B21] included 1,590 cases with laboratory-confirmed COVID-19 acute respiratory disease from 575 hospitals. This nationwide analysis revealed a higher percentage of cancer in patients with SARS-CoV-2 than in the general Chinese population (based on the report of cancer epidemiology in China from 2015), suspecting cancer patients being at higher risk of SARS-CoV-2 infection. Due to the very small sample size (*N* = 18) with an average age of 63.1 years (*SD* = 12.1), the results need to be interpreted with caution. In addition, the retrospective study by [@B46] including 28 COVID-19-infected cancer patients from three hospitals in Wuhan, China, with a median age of 65.0 years, revealed poor outcomes from SARS-CoV-2 infection in cancer patients, supporting the vulnerability of this patient group in the present pandemic. Cancer patients are generally more susceptible to infections due to the malignancy itself and its treatment with immunosuppressive agents, chemotherapy, or surgery ([@B32]).

Cancer patients are also a vulnerable patient group due to the psychological burden of their chronic disease ([@B15]). In fact, half of the patients with cancer suffer from acute psychological distress and one third meet the criteria for at least one mental health disorder, including anxiety and mood disorders, at a four-week prevalence ([@B23], [@B24]). The pandemic might have an impact on mental health due to the resulting uncertainty, public restrictions, physical distancing and effects on our everyday life. Previous research revealed an increased psychological burden during this pandemic, including distress, anxiety, and depression ([@B31]). [@B6] examined the psychological effect of quarantine during the pandemic indicating psychological burden for those being unable or not allowed to participate in social life. Further, people with mental disorders might be especially threatened. [@B45] suggested an increased vulnerability for worsened mental health conditions in already affected individuals during SARS-CoV-2 pandemic. [@B18] investigated 658 breast cancer patients and survivors during the SARS-CoV-2 outbreak in Hubei Province, China. The results revealed a psychological burden including high rates of anxiety, distress, depression, and insomnia in this patient group. The commentary by [@B27] stressed possible implications of SARS-CoV-2 on physical and psychosocial well-being in cancer survivors and the need for tailored, patient-centered care. Thus, the current pandemic might have not only an effect on physical but also on mental health, especially in case of preexisting vulnerability.

The psychological impact of the pandemic is associated with behavioral changes. A cross-sectional study by [@B17] investigated 324 individuals participating in an online survey. The results revealed that fear of the pandemic predicts public health-compliant behaviors, including improved hand hygiene and social distancing, and might be a functional response in the context of the pandemic. Besides the psychological impact of the pandemic affecting behavioral changes, knowledge about COVID-19 and associated protection methods has shown to influence behavioral changes associated with the pandemic. An increased situational awareness (i.e., perceived understanding) has shown to significantly increase the adoption of health behavior ([@B30]). Additionally, lower knowledge about COVID-19 has shown to be associated with dysfunctional behavior such as stockpiling ([@B8]).

Despite the rapidly growing body of literature on SARS-CoV-2, not only considering somatic but also considering psychological aspects, little is known about the pandemic's impact on mental health and health related safety behavior of vulnerable patient groups as patients with cancer are. To close this gap, we conducted the present investigation of the psychological burden of the SARS-CoV-2 pandemic on cancer patients. By investigating distress, health status, general anxiety, COVID-19-related fear and associated behavioral changes \[i.e., adherent safety behavior (ASB) and dysfunctional safety behavior (DSB)\] in cancer patients and comparing these to a propensity matched (10 variables) healthy control group, we aimed to give insights to the psychological burden and the needs of patients with cancer during this pandemic. More specifically, we expected cancer patients, as a vulnerable patient group, to be especially burdened by the current pandemic with increased distress, general anxiety, and COVID-19-related fear compared to healthy controls. Further, cancer patients were expected to report more associated behavioral changes compared to healthy controls. As the literature revealed COVID-19-related behavioral changes to be associated with fear and knowledge about the pandemic, we included these as possible predictors. More specifically, we expect safety behavior, adherent and DSB, to be predicted by cancer diagnosis, COVID-19-related fear, and subjective level of information.

Materials and Methods {#S2}
=====================

Procedure {#S2.SS1}
---------

Over the course of 14 days (March 16 to 30, 2020), during the first days of the SARS-CoV-2 pandemic in Germany, we distributed the survey to cancer patients of the University Hospital Essen. They were contacted for follow-up assessment and asked to participate in the anonymous online survey (response rate: 85.79%). The healthy control group was derived out of a German population based community sample (*N* = 12,863) reported in previous research ([@B5]; [@B38]). The respective anonymous online survey was distributed through online channels. To control for time inconsistency, only participants who answered the survey in the same period (March 16 to 31, 2020) were considered. Eligibility requirement was adult age (≥18 years) for all participants. All participants gave written informed consent. This study was registered at the German Clinical Trials Register with an ethical approval (19-8834-BO) by the medical faculty of the University Duisburg-Essen, registration ID: DRKS00021164.

Propensity Score Matching {#S2.SS2}
-------------------------

To account for the differences in the two samples, healthy controls were matched to cancer patients using propensity score matching (PSM; [@B20]) for conditioning our large set of covariates ([@B33]; [@B39]). Besides sociodemographic variables, we included mental disorder and somatic diseases as covariates. More specifically, cardiovascular disease, respiratory disease, hypertension, and diabetes are associated with an increased psychopathology ([@B26]; [@B10]; [@B9]; [@B28]). Further, as individuals suffering from these diseases are considered especially vulnerable to SARS-CoV-2 ([@B44]) they might feel even more burdened. Therefore, these variables were included as covariates. Cases were matched using the following covariates with percent balance improvement included: education (100.00%), age (98.89%), marital status (96.38%), gender (86.49%), city size (75.58%), somatic diseases including hypertension (94.60%), cardiovascular diseases (91.91%), diabetes (64.26%), and respiratory diseases (53.47%), as well as mental disorders (91.96%). To estimate the effect of a specific variable, in our case cancer diagnosis, PSM attempts to remove bias due to the observed confounding covariates ([@B33]). Inferences about cancer diagnosis made by using PSM are valid only if both groups have similar distributions of baseline covariates ([@B2]). The propensity score was estimated using logistic regression. We checked that the propensity score and covariates were balanced across both groups. Each cancer patient was matched to a healthy control on propensity score. Further analysis was based on this new sample. Further details can be found in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}.

Assessment Instruments {#S2.SS3}
----------------------

Socio-demographic data was assessed including age, gender, education, marital status, occupation, residential situation, as well as physical and psychological health status. Additionally, in cancer patients type of cancer, tumor-stage, and current treatment (e.g., adjuvant treatment and palliative treatment) was assessed. All data was self-reported.

Health status was assessed using the visual analog scale item from the European Quality of Life 5 Dimensions 3 Level Version (EQ-5D-3L). The scale ranges from "0 = the worst health you can imagine" to "100 = the best health you can imagine" ([@B11]).

Self-reported anxiety and its severity was assessed by use of the Generalized-Anxiety-Disorder (GAD-7) questionnaire on a 4-point scale, ranging from "0 = not at all" to "3 = nearly every day." Scores of 5, 10, and 15 are taken as cut-off points for mild, moderate and severe anxiety, respectively ([@B36]). The internal consistency was high with a Cronbach's α of 0.901.

For the measurement of distress, we used the German Version of the distress-thermometer. It is a visual analog scale ranging from "0 = no distress" to "10 = extreme distress" ([@B25]).

For the assessment of subjective level of information about COVID-19 and recommended protection measures (e.g., "I feel informed about COVID-19"), three items were formulated. Answers were given on a 7-point Likert-scale ranging from "1 = strongly disagree" to "7 = strongly agree." The internal consistency was high with a Cronbach's α of 0.804.

COVID-19-related fear was assessed by one item ("I worry about COVID-19"). Answers were given on a 7-point Likert-scale ranging from "1 = strongly disagree" to "7 = strongly agree." Thus, higher scores indicate higher COVID-19-related fear.

For the measure of ASB and DSB, nine items were formulated to cover general recommendations by the [@B43] including physical distancing and increased hand hygiene, and reported behavioral changes in media including stockpiling. Before further analysis, the reliability was tested and one item had to be excluded. Based on the rotated component analysis by Varimax the two sub-scales were identified: the 4-item sub-scale of ASB (*M* = 6.19, *SD* = 1.03) with Cronbach's alpha of 0.738, and the 4-item sub-scale of DSB (*M* = 2.92, *SD* = 1.24) with Cronbach's alpha of 0.770. Answers were given on a 7-point Likert-scale ranging from "1 = strongly disagree" to "7 = strongly agree." The items of the two sub-scales and the corrected item-scale correlations can be found in [Supplementary Table S2](#SM1){ref-type="supplementary-material"}.

Statistical Analyses {#S2.SS4}
--------------------

Statistical analyses were carried out by use of *statistical program for social sciences SPSS* version 26 (IBM, New York). The level of significance for all analyses was set at α = 0.05. By construction there was no missing data as the survey could only be completed when all items were answered. The chi-square tests confirmed no differences in sociodemographic data between the two groups ([Table 1](#T1){ref-type="table"}). The Kolmogorov-Smirnov normality test indicated a non-normal distribution. Thus, we relied on non-parametric tests. For correlations, Spearman's *rho* was calculated. The VIF values showed no indication of multicollinearity between the predictors ([@B16]). To investigate the differences between cancer patients and healthy controls in health status, general anxiety, COVID-19-related fear, distress, subjective level of information, and associated behavioral changes, nonparametric Mann-Whitney-*U*-tests were used. Further, to test whether cancer diagnosis (dummy coded with 0 = no and 1 = yes), COVID-19-related fear and subjective level of information do predict ASB and DSB, we constructed two multiple regression models.

###### 

Sociodemographic and medical characteristics.

                                                      **Cancer**   **Healthy**                
  --------------------------------------------------- ------------ ------------- ----- ------ -------------------------------
  **Sex**                                                                                     χ^2^ (1) = 0.213, *p* = 0.644
  Female                                              78           52.0          74    49.3   
  Male                                                72           48.0          76    50.7   
  **Age**                                                                                     χ^2^ (2) = 0.954, *p* = 0.621
  \<45 years                                          17           11.3          18    12.0   
  45--75 years                                        122          81.4          125   83.3   
  \>75 years                                          11           7.3           7     4.7    
  **Marital status**                                                                          χ^2^ (4) = 7.492, *p* = 0.112
  Single                                              13           8.7           23    15.3   
  Married                                             110          73.3          93    62.0   
  In a relationship                                   15           10.0          15    10.0   
  Divorced/separated                                  6            4.0           14    9.3    
  Widowed                                             6            4.0           5     3.3    
  **Educational level**                                                                       χ^2^ (4) = 5.466, *p* = 0.243
  University education                                50           33.3          56    37.3   
  Higher education entrance qualification             46           30.7          32    21.3   
  Intermediate secondary education                    38           25.3          37    24.7   
  Lower secondary education                           16           10.7          24    16.0   
  No qualification                                    0            0             1     0.7    
  **Employment**                                                                              
  Full employment                                     36           24.0          −     −      
  Partial employment                                  15           10.0          −     −      
  Not employed                                        73           48.7          −     −      
  Sick leave                                          25           16.7          −     −      
  Other                                               1            0.7           −     −      
  **City size**                                                                               χ^2^ (3) = 2.726, *p* = 0.436
  100,000 residents                                   82           54.7          86    57.3   
  20,000 residents                                    43           28.7          33    22.0   
  5,000 residents                                     16           10.7          23    15.3   
  \<5,000 residents                                   9            6.0           8     5.3    
  **Tumor Stage**                                                                             
  I                                                   10           6.7           −     −      
  II                                                  11           7.3           −     −      
  III                                                 21           14.0          −     −      
  IV                                                  36           24.0          −     −      
  Unknown                                             72           48.0          −     −      
  **Treatment situation**                                                                     
  Curative                                            24           16.0          −     −      
  Palliative                                          24           16.0          −     −      
  Cured                                               37           24.7          −     −      
  Could not be assessed                               30           20.0          −     −      
  Currently not decidable                             35           23.3          −     −      
  **Type of cancer**                                                                          
  Bone cancer, cartilage tumor, soft-tissue sarcoma   11           7.3           −     −      
  Breast cancer                                       8            5.3           −     −      
  Cancer of the central nervous system                7            4.7           −     −      
  Cancer of the gastrointestinal tract                23           15.3          −     −      
  Cancer of the eye                                   6            4.0           −     −      
  Head and neck cancer                                10           6.7           −     −      
  Leukemia or Lymphoma                                7            4.7           −     −      
  Lung cancer                                         17           11.3          −     −      
  Skin cancer                                         36           24.0          −     −      
  Thyroid cancer                                      12           8.0           −     −      
  Urogenital cancer                                   13           8.7           −     −      
  Total                                               150          100           150   100    

Cancer of the gastrointestinal tract: anal, colorectal, esophageal, gallbladder, gastric, kidney, liver, and pancreatic cancers. Cancer of the eye: retina cell carcinoma, retinoblastoma and uveal melanoma. Urogenital cancer: bladder, cervical, and prostate cancers.

Results {#S3}
=======

Participant Characteristics {#S3.SS1}
---------------------------

The participants were 150 cancer patients and 150 healthy controls, who were matched by ten variables to the cancer patients based on their demographic data. Most of the cancer patients (52% female) were older than 45 years (88.7%) and married (73.3%). One third had completed a university degree (31.9%) and most of the participants were not employed due to, e.g., retirement (66%). The patients suffered from different types of cancer in various tumor-stages, with a mean of 30.85 months (*SD* = 45.695) since diagnosis (including first diagnosis, recidivism, and metastatic cancer) and 44.7% reporting metastatic cancer. The current treatment differed from palliative (16%), over adjuvant (16%) to adjuvant treatment completed (24.7%). The 150 healthy controls were matched as mentioned above: 49.3% female, mostly aged between 45 and 74 years (83.3%), married (62%) and living in cities with populations with more than 20,000 residents (79.3%). A total of 37.3% of the healthy controls had a completed university degree. For sample descriptions, see [Table 1](#T1){ref-type="table"}.

Comparison Between Cancer Patients and Healthy Controls {#S3.SS2}
-------------------------------------------------------

The results of the Mann-Whitney-*U*-tests showed no significant differences between cancer patients and healthy controls in regard to distress, *U* = 10,657.5, *p* = 0.428, general anxiety, *U* = 10,015.5, *p* = 0.099, and COVID-19-related fear, *U* = 10,948, *p* = 0.680. Cancer patients (*M* = 5.17, *SD* = 1.582), and healthy controls (*M* = 5.06, *SD* = 1.676) reported elevated COVID-19-related fear. Both groups reported to be equally well informed about COVID-19, *U* = 11,220, *p* = 0.967. In comparison to healthy controls, cancer patients showed a lower health status, *U* = 6,486, *p* \< 0.001, *d* = 0.787. In regard to safety behavior, cancer patients reported higher levels of ASB, *U* = 8,285, *p* \< 0.001, *d* = 0.468, and DSB compared to healthy controls, *U* = 9,599, *p* = 0.029, *d* = 0.256. For an overview see [Table 2](#T2){ref-type="table"}.

###### 

Comparisons between cancer patients and healthy controls.

                                    **Cancer patients**   **Healthy controls**              
  --------------------------------- --------------------- ---------------------- ---------- --------------
  Distress                          4.86 (2.742)          5.13 (3.1529)          10,657.5   0.428
  Health status                     66.05 (19.257)        78.99 (18.798)         6,486      \< 0.001\*\*
  General anxiety                   5.29 (4.062)          4.95 (4.932)           10,015.5   0.099
  COVID-19-related fear             5.17 (1.582)          5.06 (1.676)           10,948     0.680
  Subjective level of information   6.147 (0.781)         6.116 (0.842)          11,220     0.967
  ASB                               6.40 (0.867)          5.97 (1.133)           8,285      \< 0.001\*\*
  DSB                               3.07 (1.179)          2.77 (1.280)           9,599      0.028\*

Mean parameter values for each of the analyses are shown for cancer patients (

n

= 150) and healthy controls (

n

= 150), as well as the results of Mann--Whitney

U

tests (assuming unequal variance). ASB, adherent safety behavior; DSB, dysfunctional safety behavior. \*\* significant at the 0.01 level and \* significant at the 0.05 level.

Prediction of Adherent and Dysfunctional Safety Behaviors {#S3.SS3}
---------------------------------------------------------

The results of the regression models with cancer diagnosis (dummy coded with 0 = no and 1 = yes), subjective level of information and COVID-19-related fear predicting ASB and DSB are shown in [Table 3](#T3){ref-type="table"}. Significant predictors of ASB in the whole sample were cancer, subjective level of information and COVID-19-related fear. This model provided an explained variance of 21.5%. DSB was statistically significantly predicted by cancer, COVID-19-related fear and low subjective level of information. However, the explained variance was only 6.9%.

###### 

Regression coefficients predicting ASB and DSM.

  **DV**   **Predictor**                     ***b*^a^**   ***SE*^a^**   ***t***   ***p***
  -------- --------------------------------- ------------ ------------- --------- ---------
  ASB      (Intercept)                       2.914        0.438         6.652     \<0.001
           Cancer diagnosis                  0.391        0.106         3.696     \<0.001
           Subjective level of information   0.332        0.065         5.077     \<0.001
           COVID-19-related fear             0.203        0.033         6.239     \<0.001
  DSB      (Intercept)                       3.175        0.574         5.534     \<0.001
           Cancer diagnosis                  0.287        0.139         2.067     0.040
           Subjective level of information   --0.191      0.086         --2.230   0.026
           COVID-19-related fear             0.151        0.043         3.536     \<0.001

N = 300.

a

Unstandardized regression coefficients. Model 1: Dependent Variable (DV): adherent safety behavior (ASB). Total

R

2

= 0.215,

F

\(3\) = 27.026,

p

\< 0.001. Model 2: DV: dysfunctional safety behavior (DSB). Total

R

2

= 0.069,

F

\(3\) = 7.323, p \< 0.001.

Discussion {#S4}
==========

The present study investigated the psychological burden of cancer patients during the COVID-19 pandemic. Cancer patients showed no elevated level of distress, general anxiety, or COVID-19-related fear compared to healthy controls. Both groups showed elevated COVID-19-related fear. Cancer patients reported more ASB and DSB, such as buying larger quantities of basic food, compared to healthy controls. Safety behavior could be significantly explained by cancer diagnosis, increased COVID-19-related fear, and subjective level of information about COVID-19.

Patients with a diagnosis of cancer are a vulnerable group due to their reduced health status, increased vulnerability to infections and increased prevalence of mental health conditions such as anxiety or depression. Therefore, cancer patients were expected to be especially threatened by the current pandemic. The present data, showed no elevated level of distress, general anxiety or COVID-19-related fear in cancer patients compared to propensity matched healthy controls (10 variables). In this context, it is important to mention that both, cancer patients and healthy controls, showed elevated COVID-19-related fear and comparable rates of general anxiety, suggesting both groups feel equally threatened by the current pandemic and the associated uncertainty, public restrictions and effects on everyday life. This stresses the importance of specific, situation-based and low-threshold interventions for cancer patients and threatened people in general to reduce psychological burden ([@B3],[@B4]).

Subjective level of information was associated with reduced anxiety. Even if cancer patients are a vulnerable patient group with a reduced health status, they reported no elevated distress or anxiety compared to healthy controls. Previous research stressed the importance of information needs in cancer patients and associated psychological burden. Subjective level of information might be associated with reduced uncertainty and psychological burden and elevated feelings of control and self-efficacy ([@B12]; [@B19]; [@B29]). Here, the cancer patients reported high level of information about the pandemic and associated behavioral changes to prevent infection. This might be one explanation, why they reported no elevated level of anxiety or distress compared to healthy controls. These findings stress the importance of information about COVID-19 and necessary behavioral changes provided by health professionals and society in general to prevent psychological distress and anxiety. Alternatively, the comparable level of distress, general anxiety and COVID-19-related fear for both groups might be due to psychological impact of the acute threat of the pandemic ([@B5]; [@B7]) which might surpass the underlying psychological burden of the cancer diagnosis. As the impact of the COVID-19 pandemic on mental health has shown to vary over time ([@B38]) it might be possible that people adapt to the continuing threat of the pandemic. In a longitudinal study, [@B41] revealed that the pandemic has a continuing impact on mental health including increased distress, anxiety and depressive symptoms four weeks after the initial outbreak in the general population. Still, the continuing impact of the pandemic on mental health needs to be investigated.

Cancer patients developed adaptive coping strategies to master stressful situations effectively ([@B22]). Here, they reported more ASB, such as washing or disinfecting hands more often or avoiding public places. On the other hand, they also showed more DSB such as buying larger quantities of basic food or toilet paper, in comparison to healthy controls. In contrast to our expectations, the mean differences were only marginal. This could be due to the comparable psychological burden the two groups reported, including increased COVID-19-related fear in both groups. ASB could be significantly predicted by cancer, increased COVID-19-related fear and subjective level of information about COVID-19. Again, this stresses the importance of the subjective level of information about COVID-19 to enable ASB. In accordance with previous research by [@B17], COVID-19-related fear has been revealed as predictor of behavior change (e.g., social distancing and improved hand hygiene). In general, cancer diagnosis is associated with fear and uncertainty about the future, clinical levels of distress, anxiety, and depression. However, most patients reestablish average mood and functioning within the year after medical treatment ([@B1]). Furthermore, threatening life events such as cancer diagnosis can also be associated with positive changes and an increased functioning, termed as post-traumatic growth (PTG) ([@B37]). There is evidence that PTG is very common in cancer survivors since cancer patients already mastered threatening situations in the past due to their diagnosis and treatment ([@B35]). Thus, it might be possible that the cancer patients might have reestablished mental health comparable to healthy controls due to PTG or time since diagnosis. Therefore, they are threatened by the pandemic comparable to healthy controls. A meta-analysis concluded that positive coping styles are associated with PTG ([@B34]). Thus, the reported safety behavior by cancer patients could be interpreted as one possible way of coping with the pandemic.

While cancer diagnosis, COVID-19-related fear, and subjective level of information about COVID-19 predicted ASB by 21%. These variables explained only 6% of the variance in DSB. Previous research, investigating possible predictors of stockpiling, revealed that a perceived threat of COVID-19 predicts toilet paper stockpiling ([@B14]). In this study, only up to 12% of variance in stockpiling could be explained by the included predictors. This suggests that further research is needed to identify possible predictors of DSB.

Study Limitations {#S4.SS1}
-----------------

The present study investigates the psychological burden of cancer patients during the early phase of the COVID-19 pandemic compared to matched healthy controls based on PSM. PSM is a valuable method for conditioning a large set of covariates. However, there are limitations to consider. As the present study is a cross-sectional investigation, causality cannot be assumed. The responding oncological patient group is heterogenic. However, a substantial proportion of the present sample reported to have completed adjuvant treatment limiting generalizability of the results. Further, due to the anonymous approach non-responders could not be assessed. Thus, possible selection biases and differences between responders and non-responders could not be ruled out. Social desirability has also to be mentioned but as the survey was anonymous, the impact of social desirability could be expected to be limited. Further, as COVID-19-related fear was measured by one item, validity of the assessment could be questioned. The investigation took place in the early phase of the COVID-19 pandemic. As the impact of the COVID-19 pandemic on mental health has shown to vary over time ([@B38]) the continuing impact of the pandemic on mental health in cancer patients needs to be investigated.

Clinical Implications {#S4.SS2}
---------------------

General anxiety and COVID-19-related fear were negatively associated with subjective level of information. Further, cancer patients reported more ASB, such as washing or disinfecting hands more often or avoiding public places and this was significantly explained by subjective level of information. Thus, the findings of the present study stress the importance of information about COVID-19 and related behavioral changes by health professionals and society in general for ASB and reduced anxiety. Cancer patients showed equal levels of distress, general anxiety and COVID-19-related fear in comparison to a matched healthy control group. However, they reported elevated COVID-19-related fear, stressing the need of specific, situation-based and low-threshold interventions for burdened people and people at risk to prevent increasing psychological burden.

Conclusion {#S5}
==========

In conclusion, the COVID-19 pandemic is a threatening situation as it has a substantial impact on our everyday life, including social distancing, quarantine, and uncertainty. Cancer patients show comparable levels of distress and anxiety compared to healthy controls. Still, the COVID-19 pandemic is associated with elevated COVID-19-related fear for both groups. Therefore, specific interventions -- also community-based -- are needed to prevent anxiety and improve mental health during the COVID-19 pandemic.
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